Robotic sock could prevent ankle stiffness and blood clots after stroke
NCT ID NCT05491109
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a soft robotic sock called VACOM in 19 stroke patients who had trouble moving their ankle. The sock gently moves the ankle to prevent stiffness and improve blood flow, aiming to reduce the risk of blood clots and contractures. The trial is complete, but results are still being analyzed.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Soft robotic sock (VACOM device)
- What this could lead to
- If it works, this could offer a new way to help stroke patients regain ankle movement and reduce the risk of blood clots without extra medication.
- What could go wrong
- This was a very small study (19 people) with no phase, so results are preliminary. The device may not work for everyone, and more research is needed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
19 people
The number who actually took part.
- Started
-
Sep 2022
- Finished
-
Oct 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Acute ischemic or haemorrhagic stroke. * Affected Ankle Dorsi-Flexor MMT \< 3. * Modified Ashworth Scale (MAS) = 1+ (Ankle Dorsi-Flexor/Plantar Flexor). * Not able to ambulate without assistance except during therapy time. Exclusion Criteria: * Medically unstable. * Known pulmonary embolism (PE) or deep vein thrombosis (DVT). * Pre-existing lower limb deformity, amputation, and foot drop. * Open wound or ulcer, poor skin condition over the lower limb. * On anti-coagulation (treatment dose).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute hemorrhagic stroke are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pui Kit Tam
Singapore, 119074, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a checklist and heart monitor stop repeat strokes?
- Heart hole or stroke trigger? global registry tracks who gets closure and what happens next
- Zapping the spine while wearing a robotic ankle: a new way to help kids walk?
- Can a nurse and a neighbor help tame chronic disease?
- Can PET scans reveal hidden heart inflammation after a stroke?
- Two ways to catch a hidden heart rhythm after stroke